Abstract Submisson
Award Opportunities
  • ASA01. Which conditions appear to be best for FLASH RT in a a)  deep seated tumours b) superficial tumours (radiation type, dose rate, dose per pulse, total irradiation time) are optimal for FLASH RT?
  • ASA02. Quality assurance and real time dosimetry for FLASH RT measurement of FLASH doses, detector systems
  • ASA03. Facility Overviews; How FLASH RT is delivered: electrons, photons, protons, heavy ions: equipment involved, how beam is delivered, experimental end stations etc?
  • ASA04. FLASH radiation protection; simulation and measurement for research and clinical treatment
  • ASA05. New horizons in FLASH Laser driven ions, VHEE etc
  • ASA06. Modalities and delivery of spatially fractionated radiotherapy, experimental results
  • ASB01. Mathematical modelling of the FLASH effects: Monte Carlo and other codes
  • ASB02. Physico-Chemistry: FLASH chemistry, oxygen contribution, ROS
  • ASB03. Biology 1 in vitro studies
  • ASB04. Biology 2 in vivo pre-clinical studies
  • ASB05. FLASH and SFRT and drugs including immune radiation combinations
  • ASB06. Mechanisms: modelling of SFRT; biological mechanisms and experimental studies
  • ASC01. QA and dosimetry for the clinic
  • ASC02. TPS and clinical delivery of FLASH
  • ASC03. Veterinary studies and trials
  • ASC04. Human Clinical trials
  • ASC05. Health Economics for FLASH RT
  • ASD01. QA and dosimetry for the clinic
  • ASD02. TPS and clinical delivery of SFRT
  • ASD03. Veterinary studies and trials
  • ASD04. Human Clinical trials
  • ASD05. Health Economics for SFRT
  • ASE01. Pan European studies arising from EU projects for example INSPIRE, UHDpulse, HITRiplus and RAPTOR
  • ASE02. Challenges and successes resulting from International or national collaborations in proton and ion therapy (eg. Common dosimetry, benchmarking, international and national intercomparisons and audits, databases and datasets, animal model systems etc.
  • ASE03. Proton therapy (how to build, install, commission and operate a proton therapy centre, lessons learnt, do you need a research capability, how many patients might benefit from proton therapy, indications, other insights)
  • ASF. New Horizons at the Interface between FLASH and SFRT